Xarelto rivaroxaban: Phase III started

Bayer began the double-blind, placebo-controlled, international Phase III NAVIGATE ESUS trial to compare 15 mg oral Xarelto once daily vs. 100 mg oral aspirin once daily in about 7,000 patients with a...